{"disease":{"id":"pulmonary-emphysema","name":"Pulmonary emphysema","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":27,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"fluticasone-furoate","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnuity Ellipta","generic_name":"FLUTICASONE FUROATE","company_name":"Haleon Us Holdings","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":62,"revenue":"3100","mechanism":""},{"drug_id":"vilanterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Breo Ellipta","generic_name":"VILANTEROL","company_name":"Glaxo Grp Ltd","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":60,"revenue":"3100","mechanism":"Breo Ellipta works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"umeclidinium","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Incruse Ellipta","generic_name":"UMECLIDINIUM","company_name":"Glaxo Grp England","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"Anticholinergic","quality_score":70,"revenue":"3100","mechanism":"Umeclidinium works by blocking the M4 muscarinic acetylcholine receptor to relax airway smooth muscle and improve breathing."},{"drug_id":"tiotropium-bromide","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spiriva","generic_name":"TIOTROPIUM BROMIDE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Anticholinergic","quality_score":10,"revenue":"2500","mechanism":"Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways."},{"drug_id":"fluticasone-propionate","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cutivate","generic_name":"FLUTICASONE PROPIONATE","company_name":"Teva Pharm","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":64,"revenue":"69.0","mechanism":""},{"drug_id":"flixotide","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Flixotide","company_name":"Mundipharma Research Limited","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fluticason","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluticason","company_name":"Creighton University","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"theophyllin","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"epinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"norepinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norepinephrine Bitartrate In 5% Dextrose","generic_name":"NOREPINEPHRINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"alpha-adrenergic receptors, beta-adrenergic receptors","drug_class":"Catecholamine","quality_score":80,"revenue":null,"mechanism":"Norepinephrine constricts blood vessels and stimulates the heart."},{"drug_id":"ipratropium","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atrovent","generic_name":"IPRATROPIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"diprophylline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diphyllin","generic_name":"diprophylline","company_name":"","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B","drug_class":"diprophylline","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"orciprenaline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metaproterenol","generic_name":"orciprenaline","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"terbutaline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"bitolterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tornalate","generic_name":"BITOLTEROL","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"bitolterol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"umec","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"UMEC","company_name":"Glaxo Grp England","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":"UmeC is a small molecule drug that works by interacting with a specific target in the body."},{"drug_id":"incruse","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Incruse","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"serevent","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Serevent","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Beta-1 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrin","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"brovana","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Brovana","company_name":"Wake Forest University Health Sciences","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-3 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"noradrenaline","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Noradrenaline","company_name":"Tanta University","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"formoterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foradil","generic_name":"FORMOTEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":56,"revenue":null,"mechanism":"Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"arformoterol","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brovana","generic_name":"ARFORMOTEROL","company_name":"Lupin","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":58,"revenue":null,"mechanism":"Brovana works by activating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"fluticasone","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flonase","generic_name":"fluticasone propionate","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Inhaled/intranasal corticosteroid","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"ethylnorepinephrine","indication_name":"Pulmonary emphysema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Butanefrine","generic_name":"ethylnorepinephrine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Butanefrine works by stimulating the body's natural responses to constrict blood vessels and increase airway resistance."}],"pipeline":[],"offLabel":[],"totalMarketed":27,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06528418","title":"Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"ChromX Health","has_results":false},{"nct_id":"NCT04930289","title":"Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2000,"lead_sponsor_name":"Paragonix Technologies","has_results":false},{"nct_id":"NCT06533371","title":"Clinical-ultrasonographic Assessment of Pulmonary Emphysema","phase":"NA","overall_status":"RECRUITING","enrollment_count":1628,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03049202","title":"BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05963945","title":"Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":956,"lead_sponsor_name":"Carebot s.r.o.","has_results":false},{"nct_id":"NCT05330637","title":"Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT02719184","title":"Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)","phase":"","overall_status":"COMPLETED","enrollment_count":463,"lead_sponsor_name":"Boehringer Ingelheim","has_results":true},{"nct_id":"NCT03657121","title":"Mortality and Symptom Burden Post Hospitalisation With COPD","phase":"","overall_status":"COMPLETED","enrollment_count":447,"lead_sponsor_name":"Northumbria Healthcare NHS Foundation Trust","has_results":false},{"nct_id":"NCT03480386","title":"Home Pulmonary Rehabilitation for COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT02630316","title":"Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":326,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT02713347","title":"Advancing Symptom Alleviation With Palliative Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT02439528","title":"Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02633293","title":"An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":243,"lead_sponsor_name":"United Therapeutics","has_results":true},{"nct_id":"NCT06035120","title":"An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT07091838","title":"Lung Diffusing Capacities Normality Thresholds in Pulmonary Fibrosis and Emphysema","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy","has_results":false},{"nct_id":"NCT04932811","title":"The Lung Microbiome and Endobronchial Valve Treatment","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT03010592","title":"Studying the Airway Microenvironment in Patients Undergoing Surgical and Bronchoscopic Interventions for COPD","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Royal Brompton & Harefield NHS Foundation Trust","has_results":false},{"nct_id":"NCT00683722","title":"PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Mesoblast, Inc.","has_results":false},{"nct_id":"NCT01744093","title":"Doxycycline for COPD in HIV-Infected Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT03755505","title":"The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Asan Medical Center","has_results":false},{"nct_id":"NCT06431555","title":"Magnetic Resonance Lung Function Imaging Study of Pulmonary Fibrosis Combined With Emphysema Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":55,"lead_sponsor_name":"Beijing Chao Yang Hospital","has_results":false},{"nct_id":"NCT06163131","title":"The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility","phase":"","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT04012359","title":"Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT06003270","title":"Biological Effects of Quercetin in COPD Phase II","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT04918706","title":"Allogeneic MSC Treatment for Pulmonary Emphysema","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT06068647","title":"Ultrasound and Respiratory Physiological Signals in Lung Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05610514","title":"Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT03244059","title":"Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of Alabama at Birmingham","has_results":true},{"nct_id":"NCT02748798","title":"Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Thunder Bay Regional Health Research Institute","has_results":false},{"nct_id":"NCT02556697","title":"In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients","phase":"NA","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT04465461","title":"Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT04161235","title":"Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV","phase":"","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Pulmonx Corporation","has_results":false},{"nct_id":"NCT03653104","title":"Melodica Orchestra for Dyspnea: Safety and Feasibility Pilot","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"VA Quality Enhancement Research Intiative","has_results":false},{"nct_id":"NCT03111888","title":"Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT05572996","title":"Inhaled Treprostinil Expanded Access Program in Pulmonary Hypertension Associated With Interstitial Lung Disease","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Ferrer Internacional S.A.","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}